Thrombospondin-4 mediates TGF-β-induced angiogenesis

Area of Science:

• Cell Biology
• Molecular Biology
• Cancer Research

Background:

• Transforming growth factor-beta (TGF-β) is a cytokine with diverse roles in tissue remodeling.
• TGF-β signaling effects are context-dependent, often exhibiting distinct or opposing roles in disease progression.
• The precise mechanisms behind TGF-β's cell- and process-specific actions remain unclear.

Purpose of the Study:

• To elucidate a novel pathway mediating TGF-β1-induced angiogenesis.
• To investigate the role of thrombospondin-4 (TSP-4) in TGF-β1 signaling and endothelial cell (EC) function.
• To determine TSP-4's contribution to TGF-β1-driven tumor growth and angiogenesis in vivo.

Main Methods:

• Investigated TSP-4 expression in endothelial cells (EC) following TGF-β1 stimulation.
• Utilized SMAD3 activation assays to understand TSP-4 upregulation mechanisms.
• Employed Thbs4 knockout mice and TSP-4 shRNA in EC cultures and in vivo models.
• Administered TGF-β1 and SB-431542 (TGF-β1 inhibitor) in tumor models.

Main Results:

• TGF-β1 upregulates thrombospondin-4 (TSP-4) in ECs, mediated by SMAD3 activation.
• TSP-4 mediates pro-angiogenic effects of TGF-β1 in cultured ECs and in vivo.
• Thbs4 knockout mice showed no increase in tumor mass or angiogenesis markers upon TGF-β1 injection.
• TGF-β1 inhibition reduced tumor weight and cancer angiogenesis.

Conclusions:

• TSP-4 is a key mediator of TGF-β1-induced angiogenesis.
• The identified TSP-4 pathway contributes to TGF-β1's role in stimulating tumor growth.
• Targeting TSP-4 may offer a strategy to inhibit TGF-β1-driven tumor angiogenesis.